Fabrication of sonicated chitosan nanofiber mat with enlarged porosity for use as hemostatic materials  by Gu, Bon Kang et al.
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a  b  s  t  r  a  c  t
Electrospinning  of pure  chitosan  was employed  to  obtain  a nanoﬁbrous  hemostatic  material.  Owing to  the
water-solubility  of the  resulting  acidic  chitosan  nanoﬁbers,  the optimum  neutralization  conditions  were
identiﬁed  by  testing  various  alkaline  solutions,  so  that  an insoluble  material  could  be  achieved.  The  pore
size  and  thickness  of  the neutralized  chitosan  nanoﬁbers  mat  could  be controlled  using  ultra-sonication.
The  porosity  of  the  chitosan  mat  was  increased  from  79.9%  to  97.2%  with  ultra-sonication  treatment  foreywords:
hitosan nanoﬁbers
orosity  control
lectrospinning
ltra-sonication
1  min,  and  the  water  absorption  time decreased  from  110  s to 9  s. The  blood  clotting  efﬁciency  mea-
sured  for  the  sonicated  chitosan  nanoﬁber  mat  was  1.35-  and  3.41-fold  better  than  the  efﬁciencies  of
the  Surgicel® and  chitosan  sponge,  respectively.  In addition,  the  proliferation  of normal  human  dermal
ﬁbroblasts  on the sonicated  nanoﬁber  mat  was  found  to  be  1.4-fold  higher  than  that  on the  non-sonicated
material  after  7 days  of  culture.
 201issue  engineering
emostatics
©
. Introduction
Many biodegradable and biocompatible natural polymers have
een used to prepare scaffolds for use in tissue engineering and
rug delivery applications (Hubbel, 1995; Kim et al., 2011; Park,
ee, & Kwon, 2010; Xie, MacEwan, Li, Sakiyama-Elbert, & Xia, 2009).
mong these natural polymers, chitosan has attracted considerable
nterest owing to its advantageous biological properties (Bhattarai
t al., 2009; Desai, Kit, Li, & Zivanovic, 2008; Sangsanoh et al.,
010).
Chitosan is prepared by N-deacetylation of chitin, which is the
econd most abundant polysaccharide found in nature (Muzzarelli,
reco, Busilacchi, Sollazzo, & Gigante, 2012; Muzzarelli, 2009).
hitosan has been demonstrated to be an invaluable material in
he ﬁelds of biomedical engineering and biotechnology because
f its wound healing effect, in addition to good biocompat-
bility and biodegradability, and is currently used in a wide
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variety of applications such as cosmetics and medical materi-
als (Jayakumar, Prabaharan, Nair, & Tamura, 2010; Jayakumar,
Chennazhi, Muzzarelli, Tamura, Nair, & Selvamurugan, 2010;
Muzzarelli, 2011). The safety and biodegradability of chitosan have
been recently reviewed (Baldrick, 2010; Dash, Chiellini, Ottenbrite,
& Chiellini, 2011; Kean & Thanou, 2010). A number of studies have
demonstrated chitosan to be a potential material for use in hemo-
static applications (Chen, Wang, Wei, Mo,  & Cui, 2010; Cooper, Jana,
Bhattarai, & Zhang, 2010; Ueno, Mori, & Fujinaga, 2001). The mech-
anism by which it promotes hemostasis is known to involve the
agglutination of blood proteins and platelet activation for encour-
aging ﬁbrin clot formation (Fischer et al., 2005; Janvikul, Uppanan,
Thavornyutikarn, Krewraing, & Prateepasen, 2006; Lord, Cheng,
McCarthy, Jung, & Whitelock, 2011), possibly due to the intrinsic
polycationic properties of chitosan and its nonspeciﬁc binding to
cell membranes (Yang et al., 2008). Research aimed at elucidating
the details of the process is still ongoing (Gu et al., 2010; Malette,
Quigley, Gaines, Johnson, & Rainer, 1983; Ong, Wu,  Moochhala,
Tan, & Lu, 2008). Commercially available chitosan-based hemo-
static dressings (Clo-Sur PAD, Scion Cardio-Vascular, USA & Instant
Clot Pad, Cosmo Medical Inc., Taiwan) have several shortcomings
that limit their clinical application, including the presence of a trace
acidulous odor due to the use of acetic acid as a processing solvent.
Open access under CC BY-NC-ND license. They also have an inability to retain their shape under compression
owing to their fragility (Kang et al., 2011), meaning that the acidic
chitosan hemostatic agents are prone to collapse at the wound site.
Therefore, a safer and more effective means by which to exploit
e. 
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he hemostatic properties of chitosan in a clinical setting is highly
ought after.
Electrospinning is a versatile technique that can be used to
roduce nanoscale ﬁbers from a wide variety of natural and syn-
hetic polymers (Doshi & Renekar, 1995; Dzenis, 2004; Greiner &
endorff, 2007; Lee, Lee, Jin, & Park, 2010; Reneker & Chen, 1996).
anoﬁbers have a number of desirable characteristics such as a
igh area to volume ratio. Many researchers have reported the use
f chitosan-based nanoﬁber mats for a variety of biomedical appli-
ations, including tissue templates, artiﬁcial organs, and wound
ressings (Elsabee, Naguib, & Morsi, 2012; Geng, Kwon, & Jang,
005; Klossner, Queen, Coughlin, & Krause, 2008; Ohkawa, Cha,
im, Nishida, & Yamamoto, 2004; Schiffman & Schauer, 2008). Chi-
osan is able to be electrospun into ﬁbers with diameters in the
ange of 100 nm to a few microns; however, the pores within mate-
ials consisting nanoﬁbers are extremely small due to the random
eposition of the ﬁbers. This results in such mats generally exhibit-
ng super-hydrophobicity (Tang, Wang, & He, 2009). In addition, the
ensity of the nanoﬁbers restricts cell growth and mass transport
f nutrients and metabolic waste, and also causes slow absorbance
f water or blood through the nanoﬁbers structure. To obtain a
olymer nanoﬁber mat  that overcomes these problems, Lee et al.
eported an ultra-sonication treatment that was able to increase
ore size and the thickness of the synthetic polymeric nanoﬁbers
Lee et al., 2011).
In  this study, we investigated the potential of chitosan
anoﬁbers mats with enhanced porosity for use as hemostatic
ound dressings. Acid-free chitosan nanoﬁber mats were fabri-
ated using neutralization with subsequent electrospinning, and,
n order to improve the absorptivity of the material to water, an
ltra-sonication method was then employed. The effects of the
ltra-sonication treatment on porosity, wettability, and blood clot-
ing efﬁciency of the chitosan nanoﬁber mats were investigated,
nd the viability of normal human dermal ﬁbroblasts (NHDFs) cul-
ured on the materials was evaluated.
. Experimental
.1. Materials
Chitosan powder (average Mw,  370 kDa; deacetylation degree
5%), triﬂuoroacetic acid (TFA, ∼99% purity), dichloromethane
DCM), Na2CO3, and NaOH were purchased from Sigma–Aldrich (St.
ouis, MO,  USA). Chitosan powder was puriﬁed to remove impuri-
ies; that is, 1% chitosan powder (wt/v) was dissolved in 1% acetic
cid (v/v) at 4 ◦C until the solution became transparent, and homo-
eneous. The resulting chitosan solution was ﬁltered through glass
lters (25G2) to remove impurities. The ﬁltrate was precipitated by
dding 1 M NaOH, and washed by deionized water until neutral pH.
hen the resulting chitosan was lyophilized for 2 days (Kim, Park,
u, & Kim, 2012).
Normal  human dermal ﬁbroblast cells (NHDFs, MCTT, Korea)
ere used to evaluate cell proliferation and morphology. The
broblasts were cultured in ﬁbroblast growth medium (FGM)
ontaining 2% fetal bovine serum (FBS), 0.1% insulin, recombinant
uman ﬁbroblast growth factor-B (rhFGF-B), and 0.1% GA-1000
ntibiotic solution (Lonza, USA). Cells were used from passages
. Adherent NHDFs were rinsed thoroughly with Dulbecco’s
hosphate buffered saline (DPBS, WelGENE, Korea) and detached
sing 0.05% trypsin-EDTA (Gibco, USA) prior to seeding onto the
aterials..2. Fabrication of chitosan nanoﬁbers by electrospinning
The chitosan nanoﬁber mats were prepared directly on an alu-
inum foil-covered drum collector of the electrospinning system.olymers 97 (2013) 65– 73
Brieﬂy,  a 5% (w/v) chitosan solution was  prepared by dissolving it in
TFA/DCM (7:3, v/v). The solution was  transferred to a 10 mL  syringe
ﬁtted with a metal needle (21-gauge). The needle was located at a
distance of 15 cm from the collector. A syringe pump (KD Scien-
tiﬁc, USA) was used to feed the chitosan solution to the needle
tip at a feed rate of 1.0 ml/h. During electrospinning, the needle
of the syringe was  subjected to a voltage of 21 kV relative to the
ground collector using a high-voltage power supply (Wookyung
Tech, Korea). Electrospinning was conducted in a humidity of less
than 30% and a temperature of 20–24 ◦C. Residual solvent from the
chitosan nanoﬁber mats were removed by drying in a vacuum oven
at 30 ◦C for at least 1 day.
2.3.  Neutralization of chitosan nanoﬁber mats
As the chitosan nanoﬁber mats were soluble in water, they
were neutralized after formation in order to prevent their disso-
lution in aqueous medium. Various different alkali solutions were
used, namely, Na2CO3, NH3, and NaOH. The neutralization was per-
formed by immersing each mat in 5 M Na2CO3, 29% NH3 in aqueous
solution, or 3 M NaOH in an aqueous solution of methanol for 3 h,
30 min, and 10 min, respectively. After immersion in these solu-
tions, the nanoﬁber mats were repeatedly washed with distilled
water until a pH 7 was obtained for the washings. They were then
freeze-dried for 1 day.
2.4.  Porosity control of chitosan nanoﬁber mats using
ultra-sonication
The neutralized chitosan nanoﬁber mat  (2 cm × 2 cm or circular
diameter 15 mm)  was immersed in 10 mL  distilled water at 4 ◦C (ice
bath) after prewetted by distilled water for 10 min. Ultra-sonication
of wetted chitosan nanoﬁber was  then carried out using a VCX 750
ultra-sonicator (Sonics & Materials Inc., USA). The ultra-sonication
time was  controlled in the range of 1–4 min  with a power of 225 W.
For further characterization, the chitosan nanoﬁber mats subjected
to 1 min  ultra-sonication treatment was  chosen for analysis.
2.5. Preparation of chitosan sponge
The chitosan sponge was fabricated as described in our pre-
vious studies (Kim et al., 2012). Brieﬂy, the chitosan solutions,
prepared by dissolving 2% puriﬁed chitosan (wt/v) in 1% acetic
acid (v/v), were ultra-sonicated at 4 ◦C for 30 min  using an ultra-
sonicator to achieve different molecular-weight solutions. Then,
ultra-sonicated 2% (wt/v) chitosan solutions were diluted to 1% chi-
tosan by adding 16% (v/v) butanol (dissolved in 1% acetic acid) and
stirring for 1 h. The resulting chitosan solutions were lyophilized
for 1 day, and then washed sequentially with 100%, 70% and 50%
ethanol, and deionized water for 1 h each. The chitosan scaffolds
were then freeze-dried for 1 day.
2.6. Water absorption and blood clotting studies
The water absorption time and initial contact angle of sonicated
and non-sonicated chitosan nanoﬁber mats were measured using a
digital contact angle instrument with a CCD camera (Phoenix 150,
SEO, Korea).
The  blood clotting studies were performed according to pre-
viously reported methods, with some modiﬁcations (Madhumathi
et al., 2010; Shih et al., 2006). Blood was obtained from New Zealand
white rabbits. The blood clotting efﬁciency (hemoglobin binding) of
the chitosan nanoﬁber mats was  compared with a Surgicel® (John-
son & Johnson Medical, USA), chitosan sponge and commercial
gauze. The samples were cut into 1 cm × 1 cm squares and placed
into 50 ml  tubes. Whole blood was mixed with the anticoagulant
B.K. Gu et al. / Carbohydrate Polymers 97 (2013) 65– 73 67
Fig. 1. FE-SEM micrographs of the chitosan nanoﬁbers: (a) non-neutralized as-spun chitosan nanoﬁbers mat, and after neutralization with (b) 5 M Na CO , (c) 29% NH and
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(Fig. 1(a)) show a smooth and bead-free structure, with the average
nanoﬁber diameter measured to be 301.9 ± 30.4 nm.  Owing to the
acidity of the produced material, even a single drop of water on the
chitosan surface immediately destroyed the nanoﬁbers structure.d)  3 M NaOH in MeOH alkali aqueous solutions, (e) distribution of nanoﬁber diame
gent acid citrate dextrose (ACD) at a ratio of 9:1. A 200 l sam-
le of this blood was slowly dropped to each sample, followed by
he addition of 20 l of 0.2 M CaCl2 solution to initiate blood clot-
ing. The samples were maintained at 37 ◦C for 10 min then 25 ml
f deionized water was carefully added to each tube without dis-
urbing the clot. Subsequently, 15 ml  of solution from the tube was
aken and placed in a fresh 50 ml  centrifuge tube. The solution was
entrifuged at 1000 rpm for 1 min  and then the supernatant was
ollected and incubated at 37 ◦C for 1 h.
200 l aliquots of the solution were added to the wells of a 96-
ell plate and the level of hemoglobin binding was  determined by
easuring the absorption at 540 nm using a plate reader (Spec-
ra Max  M2e, Molecular Devices, USA), which corresponded to the
mount of hemolyzed red blood cells that were not incorporated
nto the clot.
.7.  Other characterizations
The  surface and cross sectional morphology of the chitosan
anoﬁber mats (sonicated and non-sonicated) were analyzed using
eld emission scanning electron microscopy (FE-SEM, Mira II, Tes-
an, Czech Republic) after sputter coating with gold for 5 min. All
amples were examined at an acceleration voltage of 15 kV. The
mages were analyzed using the Image pro plus software (USA) to
ssess the mat  morphology and thickness, and the diameter of the
hitosan nanoﬁbers.
The  mechanical properties of the chitosan nanoﬁber mats were
easured using a mechanical testing machine (AGS-J 500N, Shi-
adzu, Japan) at a crosshead speed of 10 mm/min. The samples
ere cut into a strip-shape (1 cm × 4 cm)  and stress versus strain
urves were obtained (n = 10).
Measurements of porosity and pore size distribution of the
onicated and non-sonicated mats were obtained using mercury
orosimetry (AutoPore IV 9500, Micromeritics, USA).
.8.  In vitro cell studies
Circular  samples 15 mm in diameter were cut from the sonicated
hitosan mat  and ﬁxed in the wells of a 24-well cell culture plate
ith stainless steel rings.
They were sterilized with 70% ethanol and UV irradiation, and
hen washed three times with PBS. NHDFs were seeded onto the
amples at a density of 1 × 104 cells/well, and the culture medium
as changed every 3 days. Cell viability was evaluated at 1, 4 and days using cell counting kit-8 (CCK-8, Dojindo, Japan). At the
ppointed time, the culture medium was removed. The cells were
ashed three times with Dulbecco’s phosphate-buffered saline
DPBS) to remove the residual culture media. Each sample was then2 3 3
cale bar: 10 m).
incubated with 300 l culture medium and 30 l of CCK-8 solution
at 37 ◦C for 4 h. The optical density (OD) of each sample was  mea-
sured at 450 nm using a plate reader (Molecular Devices, Sunnyvale,
USA). At each time point, the cells on the chitosan mat  were ﬁxed
with 2.5% glutaraldehyde and 2% formaldehyde in PBS overnight at
4 ◦C. The ﬁxed cells were then dehydrated by immersing in increas-
ing concentration of ethanol in water (30–100%) for 30 min  each.
The cell morphology on the different samples was  observed using
FE-SEM.
2.9. Statistical analysis
Quantitative data were obtained in triplicate and are presented
as mean ± standard deviation. Signiﬁcant differences (p < 0.05)
between experimental groups were determined by a Student’s t-
test.
3. Results and discussion
Chitosan  nanoﬁber mats were electrospun from a solution con-
sisting of concentrated TFA and DCM (7:3, v/v). The productivity
efﬁciency of an as-spun chitosan nanoﬁber mats were found to
be 1.2 ± 0.3 g/cm2 with ∼80 m thickness (n = 4). FE-SEM images
of the surface morphology of the as-spun chitosan nanoﬁbersFig. 2. Mechanical properties of chitosan nanoﬁbers mat  and, neutralized and soni-
cated chitosan nanoﬁbers mat  in dry and wet state: (a) neutralized dry state, (b)
sonicated dry state, (c) as-spun nanoﬁbers, (d) neutralized wet state, and (e) soni-
cated wet state.
68 B.K.  Gu et al. / Carbohydrate Polymers 97 (2013) 65– 73
Fig. 3. Cross sectional FE-SEM image of chitosan nanoﬁbers mat  after ultra-sonication treatment according to time: (a) non-sonicated (scale bar: 100 m),  (b)–(e) 1 min,
2  min, 3 min  and 4 min sonicated using ultra-sonicator (scale bar: 200 m),  and (f) distrib
chitosan  nanoﬁbers mat. The arrow marks the thickness of the chitosan nanoﬁbers mat.
Fig. 4. Porosity and pore size distribution of non-sonicated (dash line) and 1 min
sonicated (solid line) chitosan nanoﬁbers mat  using mercury porosimetry.
Fig. 5. Initial contact angle and adsorption time of water droplets on (a) the non-sonicate
surface.ution of chitosan nanoﬁbers mat  thickness. Inset images are surface morphology of
Therefore, the chitosan mats required neutralization to prevent
their dissolution in aqueous medium. 3 M NaOH and 5 M Na2CO3
solutions are often used for the neutralization of chitosan mate-
rials; however, these agents require at least 3 h of incubation in
order to achieve the required results (Sangsanoh & Supaphol, 2006).
Here, three different alkaline solutions were assessed in order to
reduce the treatment time required for sufﬁcient for neutraliza-
tion. Fig. 1(b)–(d) shows FE-SEM images of samples that were
treated with 5 M Na2CO3, 29% aqueous NH3, and 3 M NaOH in
aqueous methanol for 3 h, 30 min, and 10 min, respectively. After
neutralization, the average diameters of the chitosan nanoﬁbers
were 444.3 ± 59.5, 401.8 ± 43.9, and 356.1 ± 34.6 nm, respectively
(Fig. 1(e)). Treatment with Na2CO3 and NH3 resulted in collapse
of the nanoﬁber structure, but the average diameter of the NaOH
neutralized chitosan nanoﬁbers was observed to be similar to that
of the as-spun mat. However, the chitosan nanoﬁber structure was
destroyed after neutralization using 3 M NaOH in aqueous ethanol
(data not shown), in contrast to when aqueous methanol was  used.
d chitosan nanoﬁbers mat; (b) the sonicated chitosan nanoﬁbers mat with smooth
B.K. Gu et al. / Carbohydrate Polymers 97 (2013) 65– 73 69
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lig. 6. The hemoglobin binding efﬁciency of the sonicated chitosan nanoﬁbers, th
ponge scaffolds (**p < 0.01).
he neutralization process employing NaOH in methanol was  rela-
ively low-cost and faster than the use of the other alkali solutions.
The mechanical properties of tissue engineering scaffolds are
xtremely important, as the cells require an appropriate substrate
efore new tissue can be formed (Agarwal, Wendorff, & Greiner,
ig. 7. FE-SEM image of platelets adhesion on the chitosan nanoﬁbers mat. (a) Chitos
onicated chitosan nanoﬁbers after 10 min  of absorption, (d) and (e) sonicated and non-s
ow-magniﬁcation (scale bar: 10 m,  inset scale bar: 50 m).sonicated chitosan nanoﬁbers, the Surgicel® , the commercial gauze, and chitosan
2008).  Fig. 2 shows typical stress–strain curves of the as-spun, neu-
tralized, and sonicated chitosan nanoﬁber mats in the wet  and dry
state. It was  found that the as-spun chitosan nanoﬁbers mat  had a
tensile strength of 2.41 MPa, an elastic modulus of 0.61 MPa, and
an elongation at break of 14.1%. The data demonstrate that the
an nanoﬁbers after 10 min  of absorption in PBS, (b) and (c) sonicated and non-
onicated chitosan nanoﬁbers after 1 min  of absorption, respectively. Inset image is
70 B.K.  Gu et al. / Carbohydrate Polymers 97 (2013) 65– 73
Fig. 8. Cross-sectional image of platelets adhesion on the chitosan nanoﬁbers mat. (a) Chitosan nanoﬁbers after 10 min  of absorption in PBS, (b) and (c) sonicated and
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fon-sonicated chitosan nanoﬁbers after 10 min of absorption, (d) and (e) sonicated a
s  low-magniﬁcation (scale bar: 5 m,  inset scale bar: 10 m).
eutralized chitosan nanoﬁber mat  in the dry state was  very brit-
le, exhibiting a break strain as low as 4.1%, high stress at break
4.42 MPa), and an elastic modulus of 2.32 MPa. The neutralized
at was also tested in a wet state, with the results showing a
igniﬁcant difference in the stress–strain behavior relative to the
ry samples. The break stress was lower (1.73 MPa) by an order
f magnitude compared to the dry samples, and the elongation at
reak was higher (17.1%). In comparison, the mechanical proper-
ies of the material that was sonicated for 1 min  showed tensile
trengths of 2.56 and 0.65 MPa, elastic moduli of 1.27 and 0.03 MPa,
nd elongations at break of 4.1 and 15.3% for the dry and wet states,
espectively.
It has previously been shown that ultra-sonication can be
mployed to control the pore size and thickness of a nanoﬁber
at in order to enhance water absorption time and cell viability.
hen the synthetic polymer poly(l-lactic acid) (PLLA) was  used,
he porous 3D scaffolds was fabricated using ultra-sonication with
50 W energy (Lee et al., 2011); however, this was not effective
or producing a porous nanoﬁber structure from the natural chi-
osan polymer used in the present study. This is likely because of
he strong intermolecular hydrogen bonding between the chitosan
olecules of nanoﬁbers. Thus, a higher energy of 225 W was used
o obtain a porous chitosan nanoﬁber mat. Fig. 3 shows the dif-
erences in surface and cross section morphology of the nanoﬁbern-sonicated chitosan nanoﬁbers after 1 min  of absorption, respectively. Inset image
mats  according to ultra-sonication time. The thickness of the non-
sonicated mat  was  found to be 78.4 ± 6.3 m (Fig. 3(a)), with a
dense, bead-free mesh structure with random nanoﬁbers (inset
image). As shown in Fig. 3(b)–(e), the thicknesses of the chitosan
mats were dramatically increased with sonication time, with val-
ues of 117.9 ± 5.2, 181.9 ± 4.7, 240.8 ± 12.8, and 321.3 ± 23.2 m
for 1, 2, 3, and 4 min  sonication, respectively. The maximum thick-
ness achieved using the sonication was 300% greater than for the
non-sonicated mat. In addition, the pore size of the mat  surface was
increased after ultra-sonication treatment (inset images), although
there was little difference observed between the 1 min  and 4 min
samples.
As shown in Fig. 4, mercury porosimetry was used to quan-
titatively compare the pore size distribution and porosity of the
non-sonicated and sonicated chitosan nanoﬁber mats. The pore size
for the non-sonicated mat  was approximately 470 nm, while that
of the sonicated mat  was  much higher at around 1.1 m. More-
over, the porosity of the non-sonicated mat  was 79.9%, indicating
a dense mesh structure. The total pore volume was  6.2 ml/g, and
the total pore area was 212.6 m2/g. After ultra-sonication for 1 min,
the total pore area increased, and the porosity and pore volume
increased to 97.2% and 9.1 ml/g, respectively, indicating that the
chitosan nanoﬁber mat  expanded due to the sonication, forming
large pores.
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*p < 0.01).
Hemostatic materials should be capable of providing rapid and
ffective control of bleeding; hence their initial blood absorption
imes should be low (Neuffer et al., 2004). Fig. 5 shows the water
bsorption time and initial contact angle on the non-sonicated and
onicated chitosan nanoﬁber mats. The results indicate that the
on-sonicated mat  was less hydrophilic, with a water contact angle
f 82◦ and a complete water absorption time of 110 s. The sonica-
ed mat  exhibited a lower water contact angle of 54◦ and a greatly
uperior water absorption time of 9 s. The initial high water contact
ngle of the nanoﬁber mat  was due to the dense nanoﬁber structure
Tang et al., 2009; Zhu, Cui, Li, & Jin, 2008), but on sonication, the
ngle decreased, indicating the formation of a less dense material
ith a larger pore size and greater porosity.
After achieving such promising results using water, the next
tep was to assess how the nanoﬁber mats interacted with blood.
hus, the blood clotting efﬁciency of the sonicated material was
valuated using methodology previously reported in the literature
Madhumathi et al., 2010; Shih et al., 2006). Fig. 6 shows the results
f the blood clotting (hemoglobin binding) experiments, where a
ower hemoglobin binding efﬁciency indicates higher thrombo-
enic activity of the sample (Sun et al., 2009). The samples were
ncubated with rabbit whole blood containing an anticoagulant for
0 min  at 37 ◦C, and then the binding efﬁciency was quantiﬁed by
easuring the absorption (OD) at 540 nm.  The hemoglobin bind-
ng for the sonicated nanoﬁber mat  was found to be lower than for
he Surgicel®, the commercial gauze, and the chitosan sponge used
s an additional control. The hemoglobin binding for the sonicated
nd non-sonicated chitosan nanoﬁber mats were similar; however,
ecause the initial absorption time of blood is highly important for
chieving hemostasis, the level of platelet adhesion and clot forma-
ion were assessed after a shorter blood contact time. Figs. 7 and 8–(c) non-sonicated and (d)–(f) sonicated chitosan nanoﬁbers mat  after 1, 4 and 7
et image is low-magniﬁcation (scale bar: 20 m,  inset scale bar: 50 m; *p < 0.05,
show FE-SEM images demonstrating the adhesion of platelets and
clot formation on sonicated and non-sonicated chitosan nanoﬁber
mats after different blood absorption times. As a control group, PBS
was used instead of whole blood (Fig. 7(a)). In Fig. 7(b) and (c),
fewer platelets can be seen to have adhered to the non-sonicated
chitosan nanoﬁber mat  in comparison with the sonicated mate-
rial. In addition, the number of platelets observed on sonicated and
non-sonicated chitosan mats after 10 min  blood absorption time
was higher than after 1 min. Fig. 8 shows a cross-sectional image
of the same samples as shown in Fig. 7. It can be seen that the
blood clot was greatly increased by inﬁltrated blood at the inner
part of the chitosan mat  produced by 10 min sonication (Fig. 8(b)).
After 1 min  blood adsorption time, the difference in the level of
platelet adhesion and deposited clot formation between the soni-
cated and non-sonicated chitosan nanoﬁber mats can be easily
discerned from the cross-sectional SEM images. The clot formation
after 1 min of blood contact was greater for the sonicated material
(Fig. 8(d)) than for the non-sonicated (Fig. 8(e)). The appearance of
the non-sonicated chitosan mat  (1 min) was similar to that of the
mat  that was  immersed in PBS (Fig. 8(a)), indicating vary little blood
clot formation on this material. The increase in platelet adhesion on
the sonicated material was likely due to rapid attachment of blood
proteins such as immunoglobulin to the chitosan nanoﬁber mat
with improved pore size and porosity. The results from the blood
contacting studies are in agreement with those shown in Fig. 5 for
water absorption. In both cases, the sonicated mat, with its higher
pore size and porosity, had a much shorter liquid absorption time.
These results indicate that the sonicated chitosan nanoﬁber mat
has great potential to be used as a hemostatic agent.
To  investigate the effects of pore size on cell viability for
potential tissue engineering applications, NHDFs were cultured
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n sonicated and non-sonicated chitosan nanoﬁber mats for 1, 4,
nd 7 days. Fig. 9 shows that the optical density (OD) values that
epresent the number of cells present on the non-sonicated and
onicated chitosan mats demonstrated that there was  a similar
ell growth pattern after 1 day of culture. However, after 7 days,
he OD value from the sonicated sample (1.24 ± 0.02) was higher
han for the non-sonicated sample (0.89 ± 0.02). This demonstrates
hat the cells cultured on the sonicated chitosan nanoﬁber mat  had
n approximately 1.4-fold higher viability than those on the non-
onicated mat  under the same culture conditions. This result was
ikely due to the enhanced cellular attachment and mass transport
f nutrients and metabolic waste possible for the sonicated mat,
eading to higher cell proliferation.
Therefore,  the sonicated chitosan nanoﬁber mat, with its
nhanced porosity and wettability, would be a good candidate for
se as both a tissue engineering scaffold and a hemostatic mate-
ial, providing higher cell adhesion and growth in addition to rapid
lood coagulation.
.  Conclusions
Pure chitosan nanoﬁbers were prepared by electrospinning,
ith control over pore size and mat  thickness achieved using ultra-
onication. The optimum neutralization conditions for the chitosan
anoﬁbers were identiﬁed by testing various alkaline solutions. The
hickness and porosity of the mats could be controlled by varying
he ultra-sonication time. The sonicated chitosan nanoﬁber mats
ere more porous and the water absorption time was improved
rom 110 s to 9 s. The blood clotting efﬁciency of the sonicated chi-
osan nanoﬁber mat  was superior to that observed for the Surgicel®,
nd chitosan sponge controls. Additionally, cell viability on the
onicated mat  was found to be 1.4-fold higher than for the non-
onicated mat. These results suggest that the sonicated chitosan
anoﬁber mat  has great potential for use in tissue engineering
pplications and as a hemostatic wound dressing.
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